Literature DB >> 26282784

Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.

Sheng-Xian Yuan1, Jin Zhang1, Qing-Guo Xu1, Yuan Yang1, Wei-Ping Zhou2.   

Abstract

The epigenetic mechanism that incorporates DNA methylation alterations, histone modifications, and non-coding RNA expression has been identified as a major characteristic in distinguishing physiological and pathological settings of cancers including hepatocellular carcinoma (HCC), the third leading cause of mortality related cancer. The advance in methylation modification of chromatin elements (for both genomic DNA and histone tails) and the emerging roles of long noncoding RNA (lncRNA) have given us a better understanding of molecular mechanisms underlying HCC. Recently, methods like genome-wide lncRNA profiling and histone hallmark detection were reported to discover mass tumor-associated lncRNAs epigenetically deregulated by differential chromosome modification, mainly by genomic DNA and histone methylation. Therefore, aberrant methylation modification of certain particular lncRNA genes could be crucial events correlating with unfavorable outcomes in HCC. In addition, amount of lncRNAs could act as a manipulator for DNA methylation or a scaffold for histone modification to affect key signaling pathways in hepatocarcinogenesis. This suggests that methylation modification of chromatin elements may have functional crosstalk with lncRNA. Here, we aim to outline the emerging role of the methylation and lncRNA, and their crosstalk of molecular mechanism.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Epigenetic; Hydroxymethylation; Long noncoding RNA; Methylation; Tumor

Mesh:

Substances:

Year:  2015        PMID: 26282784     DOI: 10.1016/j.canlet.2015.08.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.

Authors:  Kai Chen; Yifu Hou; Rui Liao; Youzan Li; Hongji Yang; Jun Gong
Journal:  Oncogene       Date:  2021-04-06       Impact factor: 9.867

2.  Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.

Authors:  Yang Bai; Haiping Lin; Jiaqi Chen; Yulian Wu; Shi'an Yu
Journal:  Front Mol Biosci       Date:  2021-04-22

3.  Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.

Authors:  Mingwei Chen; Jianfa Li; Chengle Zhuang; Zhiming Cai
Journal:  Oncotarget       Date:  2017-04-25

4.  Long non-coding RNA PARTICLE bridges histone and DNA methylation.

Authors:  Valerie Bríd O'Leary; Sarah Hain; Doris Maugg; Jan Smida; Omid Azimzadeh; Soile Tapio; Saak Victor Ovsepian; Michael John Atkinson
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

5.  LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.

Authors:  Qing-Chun Lu; Zhuang-Hua Rui; Zhong-Liang Guo; Wang Xie; Shan Shan; Tao Ren
Journal:  J Cell Mol Med       Date:  2017-12-20       Impact factor: 5.310

6.  Long non-coding RNA XIST promotes extracellular matrix degradation by functioning as a competing endogenous RNA of miR-1277-5p in osteoarthritis.

Authors:  Tao Wang; Yize Liu; Yong Wang; Xuyang Huang; Wei Zhao; Zhonghai Zhao
Journal:  Int J Mol Med       Date:  2019-06-12       Impact factor: 4.101

7.  Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.

Authors:  Weiwei Wang; Guoyong Chen; Bing Wang; Zhenhua Yuan; Guangbo Liu; Biao Niu; Yongfeng Chen; Shaotang Zhou; Junchuang He; Huanzhou Xue
Journal:  J Transl Med       Date:  2019-12-17       Impact factor: 5.531

8.  Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α-tubulin acetylation in breast cancer.

Authors:  X-H Liao; J-G Wang; L-Y Li; D-M Zhou; K-H Ren; Y-T Jin; L Lv; J-G Yu; J-Y Yang; Q Lu; Q Zou; J Yu; X-P Liu; P Zhou
Journal:  Cell Death Dis       Date:  2016-05-26       Impact factor: 8.469

9.  Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.

Authors:  Kun Liu; Yuening Zhang; Chengdong Zhang; Qinle Zhang; Jiatong Li; Feifan Xiao; Yingfang Li; Ruoheng Zhang; Dongwei Dou; Jiezhen Liang; Jian Qin; Zhidi Lin; Dong Zhao; Min Jiang; Zhenxin Liang; Jie Su; Vanaparthy Pranay Gupta; Min He; Xiaoli Yang
Journal:  Oncotarget       Date:  2016-08-30

Review 10.  The role of long noncoding RNAs in hepatocellular carcinoma.

Authors:  Zhao Huang; Jian-Kang Zhou; Yong Peng; Weifeng He; Canhua Huang
Journal:  Mol Cancer       Date:  2020-04-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.